Australian State and South Korea to Work on the Development of the Global RNA Ecosystem
A case of test tubes is placed on a lab table during research on coronavirus, COVID-19, at Johnson & Johnson subsidiary Janssen Pharmaceutical in Beerse, Belgium, Wednesday, June 17, 2020. Janssen Pharmaceutical hopes to begin clinical trials on a potential vaccine for COVID-19 in the middle of the summer. Virginia Mayo/AP Photo
The Australian state of Victoria and South Korea are joining forces to enhance RNA and mRNA vaccine research capabilities.
The partnership was formalised by the signing of a memorandum of understanding (MOU) between mRNA Victoria and the South Korea Health Industry Development Institute (KHIDI).
